Assisted Reproductive Technology (Art) Market Size to grow by USD 6295.3 million between 2024-2028
According to a research report “ Assisted Reproductive Technology (Art) Market” by Application (Fertility clinics, Hospitals, Others) Type (IVF, Artificial insemination) Geography (Europe, North America, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 6295.3 million, at a CAGR of over 4.36% during the forecast period. The global Assisted Reproductive Technology (ART) market experiences significant growth due to escalating infertility and obesity-related cases. Infertility, a prevalent issue affecting numerous couples, is driven by factors such as advanced maternal age, hormonal disorders, lifestyle choices, genetic factors, and infections. As the incidence of infertility continues to escalate, the demand for ART procedures like In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and other advanced reproductive technologies increases, propelling market expansion.
Browse market data tables, figures, and in-depth TOC on “Assisted Reproductive Technology (Art) Market” by Application (Fertility clinics, Hospitals, Others) Type (IVF, Artificial insemination) Geography (Europe, North America, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Application, the Fertility clinics segment is projected to dominate the market size in 2024
The Assisted Reproductive Technology (ART) market represents a significant segment of In Vitro Fertilization (IVF) procedures. IVF is a medical innovation that facilitates fertilization of eggs with sperm outside a woman's body in a laboratory setting. Subsequently, the resulting embryos are transferred back into the uterus to initiate pregnancy. IVF has transformed reproductive medicine, offering hope to couples grappling with infertility or other reproductive challenges. Common indications for IVF include female infertility due to fallopian tube blockages, endometriosis, ovulation disorders, and male infertility stemming from low sperm count or poor sperm quality. The ART market has witnessed robust growth in recent years, fueled by heightened awareness and acceptance of these technologies, advancements in laboratory techniques, and a burgeoning trend of deferred parenthood among couples.
By Type, IVF segment is expected to hold the largest market size for the year 2024
The global Assisted Reproductive Technology (ART) market is witnessing significant growth due to the proliferation of fertility clinics worldwide. This trend is driven by the rising number of infertility patients, fueled by an increase in the success rates of these clinics. In the context of a fertility clinic, success is measured by the number of treatments administered and the resulting pregnancies or live births. Highly successful clinics, therefore, emerge as popular destinations for infertility treatments, not only in their domestic markets but also on the international stage, throughout the forecast period.
Europe is forecasted to hold the largest market size by region in 2024
The Assisted Reproductive Technology (ART) market encompasses innovative solutions that enhance fertility and pregnancy rates for individuals and couples facing infertility. This sector's growth is driven by advancements in reproductive medicine, increasing awareness, and a rising global population seeking family expansion. Key players in this industry focus on developing cutting-edge technologies, expanding their reach, and ensuring regulatory compliance.
The Assisted Reproductive Technology (Art) Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Assisted Reproductive Technology (ART), which includes Frozen Non-Donor IVF and other fertility treatments, has revolutionized the way couples, particularly women and men, conceive and start families. With the use of gametes (sperm and eggs) and embryos from the couple themselves, Frozen Non-Donor methods offer an alternative to Fresh Non-Donor methods, providing greater flexibility and reducing the risk of prematurity and associated health issues. However, ethical concerns surrounding ART persist. The World Health Organization (WHO) emphasizes the importance of informed consent, non-discrimination, and respect for human dignity. Socio-ethical issues include the impact of stressful lifestyles, late marriages, and societal norms on female fertility. Same-sex marriages and surrogacy also raise complex ethical questions. Factors such as fertility drugs, pre-existing medical conditions, and lifestyle choices like drug addiction, alcoholism, and smoking can affect the success of ART and the health of the resulting children. The Crude Birth Rate indicates a global need for accessible and affordable fertility treatments. As ART continues to evolve, addressing these challenges and ensuring ethical practices remains crucial. The reproductive process involves various organs such as the placenta, vagina, and uterus. Understanding their roles and the intricacies of ART can help individuals make informed decisions about their reproductive health.
Market Research Overview
Assisted Reproductive Technology (ART) market encompasses various fertility treatments for women and men, including Frozen non-donor IVF, Intrauterine Insemination (IUI), Ovulation Induction, and Cryopreservation of gametes and embryos. The use of Frozen non-donor eggs and sperm has become increasingly popular due to their longer shelf life and reduced success rate compared to Fresh non-donor gametes. However, ethical issues surrounding ART continue to arise, particularly in relation to the use of donor gametes and embryos, as well as the potential health risks for women, such as premature births and stress on the placenta, vagina, uterus, and ovaries. Socio-ethical concerns also include the impact of fertility drugs, stressful lifestyles, late marriages, and female fertility on the ART market. same-sex marriages, single women, and minor fertility conditions are also significant consumers of ART. Socio-ethical issues surrounding ART include the use of frozen donor eggs and sperm, fertility medication, and surrogacy. The World Health Organization and organizations like the Human Rights Campaign advocate for ethical practices and regulations in ART. Factors such as drug addiction, alcoholism, and smoking can also impact the success rate of ART. The global CRUDE birth rate is expected to increase the demand for ART in the coming years.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
